IVF center in Italy: what international patients should check

PMA is the Italian term for medically assisted reproduction. According to the Italian Ministry of Health, first-level methods are less complex and fertilization takes place within the female reproductive system, while second- and third-level methods involve in-vitro fertilization. A level describes authorized technical complexity; it is not a score or league table.

Read the Italian Ministry’s ART overview

• Is the center currently authorized, and does its registry record include the technique being considered?
• How are female and male factors, previous treatment and recurrent pregnancy loss assessed before a protocol is proposed?
• Who coordinates monitoring, laboratory stages and communication when the patient lives outside Rome?
• Are prices clear about consultations, tests, medicines, laboratory work, cryopreservation and later transfers?
• When results are quoted, are the period, sample size, age group and outcome definition stated?

Biofertility’s official record reports IUI, ICSI and IVF, as well as the donation-cycle and cryopreservation activities shown there. The clinical pathway begins with the couple’s history and available tests before a treatment is selected. Patients outside Rome can share existing records and clarify which assessments may be coordinated locally; the care team confirms when attendance in Rome is necessary.

• Clinic locations and official authorization
• IVF, ICSI, IUI and ART treatments
• Current fee-schedule information
• Information for patients outside Rome

Before booking travel, ask the team which original documents, recent tests and translations are required, which visits must take place in Rome, and how medication and monitoring will be coordinated. Travel dates should follow the clinical plan rather than a generic timetable because ovarian response and individual needs can change the schedule.

When entered from the English site, Biofertility’s digital booking, payment, invoice and privacy steps remain in English. This administrative support does not replace clinical advice or procedure-specific informed consent.

The content of this website follows the principles of the Italian Code of Medical Ethics issued by FNOMCeO and the guidance of the Medical Association (Ordine dei Medici) of Rome on healthcare information.

• Information, not advertising. Article 56 of the Code allows truthful and verifiable healthcare information with an informative purpose rather than a commercial one: no offers, discounts or promises of results are presented here.
• Truthfulness and verifiability. Information about the centre can be checked against institutional sources, and the physician’s registration can be verified with the Medical Association.
• Transparency about roles and places. The person responsible for the centre and the medical director are named, together with the address where MAR procedures are carried out and the one used for private gynaecological practice.
• Caution with outcome data. Any results are published only with the indicator, period, sample and age range, and without comparisons with other facilities.
• Confidentiality. No clinical data, stories or images attributable to individual patients are published; health data is exchanged through protected channels, never ordinary email.
• Responsible use of digital channels. FNOMCeO recommendations on social media and messaging rule out clinical consultations and the exchange of health data through comments, ordinary messages or groups.

Official sources:FNOMCeO — article 56,the full Code of Medical Ethics,recommendations on social media and messaging,the Rome Medical Association register. Provisions on advertising in the healthcare sector introduced by Decree-Law 69 of 13 June 2023 are also taken into account.

Referring to these sources describes the criteria applied when drafting the content of this website; it is not a certification of compliance issued by a third party.